Medical News

RSS

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.

23 Jul 2010

States still hoping for extra Medicaid money but also developing contingency plans

Kaiser Health News reports that states and hospital groups continue to lobby for a six-month extension of enhanced Medicaid money despite funding concerns and the lack of a way forward for such an extension.

23 Jul 2010

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

On the 20th anniversary of the signing of the Americans with Disabilities Act, a new survey sponsored by Kessler Foundation and National Organization on Disability finds that most Americans with disabilities are still struggling with many of the same lifestyle and economic issues they confronted in 1990 when the ADA became federal law.

23 Jul 2010

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.

23 Jul 2010

MAXIMUS operates health care appeal programs for state regulatory agencies

The United States Departments of Health and Human Services, Labor and the Treasury announced yesterday a new internal claims and appeals and external review process for group health plans under the Patient Protection and Affordable Care Act.

23 Jul 2010

CRF Health collects prestigious IPA Best of Health Awards

CRF Health garnered nine awards recently in the Business-to-Business categories of the Institute of Practitioners in Advertising Best of Health Awards, for their bold, new communications aimed at healthcare professionals involved in clinical trials. The awards were collected by their creative agency behind the campaign, Langland, at the awards night in London.

23 Jul 2010

Applications accepted for September 2010 CMPP examination

Applications are now being accepted for the September 2010 Certified Medical Publication Professional examination. Qualified candidates can take the three-hour exam during the September 1-30, 2010 testing window at approved locations around the globe.

23 Jul 2010

Renhuang awarded AAA(1) rating

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that the Company was recently awarded an AAA(1) rating by Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce.

23 Jul 2010

Titan anticipates second-quarter Fanapt royalty payment of $55,000

Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.

23 Jul 2010

IPC signs agreement with UCSF to develop leadership training program for physician managers

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has entered into an agreement with the University of California, San Francisco Division of Hospital Medicine and its Center for the Health Professions to develop a leadership training program for dozens of IPC's key physician managers.

23 Jul 2010

Advanced Life Sciences enters debt for equity exchange agreement with CEO

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has entered into a debt for equity exchange agreement with its chairman and CEO Michael T. Flavin, Ph.D.

23 Jul 2010

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Emisphere Technologies, Inc. today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s have reported the following in connection with their Phase III Study 2302 in osteoarthritis assessing the safety and efficacy of oral calcitonin in the treatment of osteoarthritis of the knee.

23 Jul 2010

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Unigene Laboratories, Inc. announced today that Novartis and its license partner Nordic Bioscience have decided to continue the companies' two-year, Phase III Study 2302 assessing safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee. Novartis has a worldwide license to produce recombinant calcitonin under Unigene's patented SecraPep® E. coli manufacturing technology.

23 Jul 2010

Vermillion to complete relocation of corporate offices to Austin, Texas by September 2010

Vermillion, Inc., a molecular diagnostics company, today announced that it is relocating its corporate headquarters from Fremont, California to Austin, Texas. Vermillion has executed a two-year lease for a new principal place of business at 12117 Bee Cave Road, Building Two, Suite 100, Austin, TX 78731. Vermillion will continue to operate research and development, regulatory and quality operations in California. All other functions will be conducted at the Austin offices.

23 Jul 2010

Expert to speak on challenges, issues in development, implementation of REMS

At two Food and Drug Administration meetings, Sidney H. Schnoll, MD, PhD, Vice President, Pharmaceutical Risk Management Services of PinneyAssociates, will discuss the need for predictability, feasibility and transparency to ensure that Risk Evaluation and Mitigation Strategies benefit patient safety and public health.

23 Jul 2010

Achieving meaningful use of inpatient EHR is top priority of hospital executives: Survey

According to a survey of U.S. hospital executives released today by CSC, steps to meet meaningful use requirements were already a priority for hospitals before the final rules to establish an incentive program for electronic health records were announced by the United States Department of Health and Human Services (HHS) on July 12.

23 Jul 2010

AVAC releases GPP Guidelines at International AIDS Conference

The draft second edition of The Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials were released yesterday at the International AIDS Conference in Vienna by AVAC. The GPP Guidelines aim to provide trial funders, sponsors, and implementers with systematic guidance on how to effectively work with a range of stakeholders as they design and conduct biomedical HIV prevention trials.

23 Jul 2010

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

IDEXX Laboratories, Inc., today reported that revenues for the second quarter of 2010 increased 6% to $281.5 million, from $265.7 million for the second quarter of 2009. Organic revenue growth, as defined below, was 5%. Earnings per diluted share for the quarter ended June 30, 2010 increased 13% to $0.62, compared to $0.55 for the same period in the prior year.

23 Jul 2010

Vienna Declaration signed to support evidence-based drug policy for improving community health

Sandra Roelofs, First Lady of Georgia; George Tsereteli, Georgia's Deputy Chairman of Parliament; and Irakli Giorgobiani, Georgia's Vice Minister of Labour, Health and Social Affairs, today signed the Vienna Declaration, the official declaration of the XVIII International AIDS conference in Vienna, Austria.

23 Jul 2010

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, has entered into a long-term, 10-year exclusive distribution agreement with Japanese-based Nikkiso Co. Ltd. for hemodialysis and peritoneal dialysis products in Japan.

23 Jul 2010

Medical News

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

States still hoping for extra Medicaid money but also developing contingency plans

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

MAXIMUS operates health care appeal programs for state regulatory agencies

CRF Health collects prestigious IPA Best of Health Awards

Applications accepted for September 2010 CMPP examination

Renhuang awarded AAA(1) rating

Titan anticipates second-quarter Fanapt royalty payment of $55,000

IPC signs agreement with UCSF to develop leadership training program for physician managers

Advanced Life Sciences enters debt for equity exchange agreement with CEO

Update on Phase III Study of oral calcitonin for treatment of osteoarthritis

Novartis, Nordic Bioscience to continue oral calcitonin Phase III study in osteoarthritis patients

Vermillion to complete relocation of corporate offices to Austin, Texas by September 2010

Expert to speak on challenges, issues in development, implementation of REMS

Achieving meaningful use of inpatient EHR is top priority of hospital executives: Survey

AVAC releases GPP Guidelines at International AIDS Conference

IDEXX Laboratories second-quarter 2010 revenues increase 6% to $281.5 million

Vienna Declaration signed to support evidence-based drug policy for improving community health

Fresenius Medical Care, Nikkiso enter 10-year exclusive distribution agreement for dialysis products in Japan

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News